AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 24591191 — intervention group
Group type: EXPERIMENTAL
Intervention: Sublingual administration of D. farinae drops for 48 weeks
Number of subjects: 60
Study 24591191 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 48 weeks
Number of subjects: 60
Study 22112683 — intervention group
Group type: EXPERIMENTAL
Intervention: Prior warfarin only
Number of subjects: 14090
Study 22112683 — intervention group
Group type: EXPERIMENTAL
Intervention: Prior ASA and warfarin
Number of subjects: 14090
Study 22112683 — intervention group
Group type: COMPARATOR
Intervention: No prior therapy
Number of subjects: 14090
Study 22112683 — intervention group
Group type: COMPARATOR
Intervention: Prior ASA only
Number of subjects: 14090
Study 20391870 — intervention group
Group type: EXPERIMENTAL
Intervention: Chain training (attached chains at 5% of weight)
Number of subjects: 19
Study 20391870 — intervention group
Group type: COMPARATOR
Intervention: Traditional training (conventional equipment)
Number of subjects: 19
Study 17975496 — intervention group
Group type: EXPERIMENTAL
Intervention: Temsirolimus 25 mg
Number of subjects: 85
Study 17975496 — intervention group
Group type: EXPERIMENTAL
Intervention: Temsirolimus 250 mg
Number of subjects: 85
Study 17975496 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall (both doses)
Number of subjects: 85
Study 17975496 — intervention group
Group type: EXPERIMENTAL
Intervention: Toxicities reported
Number of subjects: 85
Study 15777522 — intervention group
Group type: EXPERIMENTAL
Intervention: Moxifloxacin (1000 mg total dose, single blind, one day oral provocation test)
Number of subjects: 20
Study 12467997 — intervention group
Group type: EXPERIMENTAL
Intervention: Secondary-concomitant fibromyalgia (SCFS)
Number of subjects: 145
Study 12467997 — intervention group
Group type: EXPERIMENTAL
Intervention: Fibromyalgia (FS)
Number of subjects: 145
Study 12467997 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiregional pain with at least 11 tender points (MPTE)
Number of subjects: 145
Study 12467997 — intervention group
Group type: EXPERIMENTAL
Intervention: Widespread pain (WP)
Number of subjects: 145
Study 12467997 — intervention group
Group type: EXPERIMENTAL
Intervention: Diffuse multiregional pain (MP)
Number of subjects: 145
Study 12467997 — intervention group
Group type: COMPARATOR
Intervention: Healthy subjects (HS)
Number of subjects: 145
Study 12467997 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold pressure test
Number of subjects: 145
Study 12467997 — intervention group
Group type: EXPERIMENTAL
Intervention: Von Frey test
Number of subjects: 145
Study 12467997 — intervention group
Group type: EXPERIMENTAL
Intervention: Tourniquet test
Number of subjects: 145
Study 9481595 — intervention group
Group type: EXPERIMENTAL
Intervention: Reduced fat diet
Number of subjects: 220
Study 9481595 — intervention group
Group type: EXPERIMENTAL
Intervention: Full fat diet
Number of subjects: 220
Study 7893790 — intervention group
Group type: EXPERIMENTAL
Intervention: Amoxycillin for 10 days
Number of subjects: 58
Study 7893790 — intervention group
Group type: EXPERIMENTAL
Intervention: Amoxycillin/clavulanic acid for 10 days
Number of subjects: 58
Study 7893790 — intervention group
Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 58
Study 7893790 — intervention group
Group type: EXPERIMENTAL
Intervention: Amoxycillin and Amoxycillin/clavulanic acid
Number of subjects: 58
Study 7893790 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall
Number of subjects: 58
Study 2695999 — intervention group
Group type: EXPERIMENTAL
Intervention: Personalized prescription
Number of subjects: 180
Study 2695999 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard prescription)
Number of subjects: 180
Study 2695999 — intervention group
Group type: EXPERIMENTAL
Intervention: Interview method for evaluation
Number of subjects: 180
Study 405408 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium cromoglycate (SCG) 4% solution instilled into each eye 4 times daily
Number of subjects: 30
Study 405408 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 31801712 — intervention group
Group type: EXPERIMENTAL
Intervention: Qingshen Granules (3 times a day)
Number of subjects: 60
Study 28107729 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant LH (rLH) supplementation (75 IU daily from day 7 of FSH stimulation to the day of HCG trigger)
Number of subjects: 100
Study 28107729 — intervention group
Group type: COMPARATOR
Intervention: No additional rLH supplementation (control group)
Number of subjects: 100
Study 25190522 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 mg intranasal nicotine
Number of subjects: 89
Study 23608774 — intervention group
Group type: EXPERIMENTAL
Intervention: Levobupivacaine 0.25% 1 ml/kg plus sufentanil 0.5 μg/kg (Group LS)
Number of subjects: 62
Study 23608774 — intervention group
Group type: COMPARATOR
Intervention: Levobupivacaine 0.25% 1 ml/kg only (Group L)
Number of subjects: 62
Study 22229181 — intervention group
Group type: EXPERIMENTAL
Intervention: centrum combined with interbody bone graft fusion (group A)
Number of subjects: 126
Study 22229181 — intervention group
Group type: EXPERIMENTAL
Intervention: posterolateral bone graft fusion (group B)
Number of subjects: 126
Study 22229181 — intervention group
Group type: EXPERIMENTAL
Intervention: ring bone graft fusion (group C)
Number of subjects: 126
Study 19423996 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture plus self-care
Number of subjects: 267
Study 19423996 — intervention group
Group type: COMPARATOR
Intervention: Self-care alone
Number of subjects: 267
Study 17545185 — intervention group
Group type: COMPARATOR
Intervention: Compression alone
Number of subjects: 500
Study 17545185 — intervention group
Group type: EXPERIMENTAL
Intervention: Compression plus surgery
Number of subjects: 500
Study 16123223 — intervention group
Group type: EXPERIMENTAL
Intervention: R-CHOP (CHOP combined with rituximab)
Number of subjects: 428
Study 16123223 — intervention group
Group type: COMPARATOR
Intervention: CHOP alone
Number of subjects: 428
Study 12005088 — intervention group
Group type: EXPERIMENTAL
Intervention: q48h dosing schedule (5.0 or 4.5 mg/kg/dose q48h)
Number of subjects: 58
Study 12005088 — intervention group
Group type: COMPARATOR
Intervention: q24h dosing schedule (2.5 or 3.0 mg/kg/dose q24h)
Number of subjects: 58
Study 12005088 — intervention group
Group type: EXPERIMENTAL
Intervention: q48h dosing schedule
Number of subjects: 58
Study 12005088 — intervention group
Group type: COMPARATOR
Intervention: q24h dosing schedule
Number of subjects: 58
Study 9597523 — intervention group
Group type: EXPERIMENTAL
Intervention: Abciximab
Number of subjects: 0
Study 9597523 — intervention group
Group type: COMPARATOR
Intervention: Control (standard therapy)
Number of subjects: 0
Study 7806674 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorhexidine (Peridex) mouthrinse applied to the lower jaw for 21 days
Number of subjects: 41
Study 7806674 — intervention group
Group type: COMPARATOR
Intervention: Placebo mouthrinse applied to the lower jaw for 21 days
Number of subjects: 41
Study 2550335 — intervention group
Group type: EXPERIMENTAL
Intervention: Kabi 2165 (low-molecular-weight heparin) 2 X 2,500 anti-Xa units s.c.
Number of subjects: 60
Study 1098181 — intervention group
Group type: EXPERIMENTAL
Intervention: Parenteral administration of cephradine
Number of subjects: 10
Study 1098181 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral administration of cephradine
Number of subjects: 10
Study 1098181 — intervention group
Group type: EXPERIMENTAL
Intervention: Open clinical trial
Number of subjects: 10
Study 31958867 — intervention group
Group type: EXPERIMENTAL
Intervention: Homeopathic Calcarea carbonica ostrearum (CCO) in addition to a multidisciplinary intervention (diet, motivational support, and exercise program)
Number of subjects: 80
Study 31958867 — intervention group
Group type: COMPARATOR
Intervention: Placebo in addition to a multidisciplinary intervention (diet, motivational support, and exercise program)
Number of subjects: 80
Study 31178434 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin alone for 12 months
Number of subjects: 267
Study 31178434 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin glargine for 3 months followed by metformin for 9 months
Number of subjects: 267
Study 31178434 — intervention group
Group type: EXPERIMENTAL
Intervention: Liraglutide combined with metformin for 12 months
Number of subjects: 267
Study 31178434 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 12 months
Number of subjects: 267
Study 28076496 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinpro XT (resin-modified glass ionomer cement)
Number of subjects: 20
Study 28076496 — intervention group
Group type: COMPARATOR
Intervention: Vidrion R (conventional glass ionomer cement)
Number of subjects: 20
Study 25291499 — intervention group
Group type: EXPERIMENTAL
Intervention: Dutasteride (0.5 mg daily for 8 weeks)
Number of subjects: 259
Study 25291499 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 259
Study 23659710 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse‐led structured diabetes care with a protocol, record keeping, reminders, feedback, and training in motivational interviewing and agenda setting
Number of subjects: 940
Study 21798658 — intervention group
Group type: EXPERIMENTAL
Intervention: OnabotulinumtoxinA 200 U
Number of subjects: 275
Study 21798658 — intervention group
Group type: EXPERIMENTAL
Intervention: OnabotulinumtoxinA 300 U
Number of subjects: 275
Study 21798658 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 275
Study 18465191 — intervention group
Group type: EXPERIMENTAL
Intervention: Photodynamic therapy (PDT) after subgingival scaling and root planing
Number of subjects: 24
Study 18465191 — intervention group
Group type: COMPARATOR
Intervention: Subgingival scaling and root planing alone (control)
Number of subjects: 24
Study 16952896 — intervention group
Group type: EXPERIMENTAL
Intervention: Panic disorder-related automatic thoughts
Number of subjects: 62
Study 16952896 — intervention group
Group type: EXPERIMENTAL
Intervention: Social phobia-related automatic thoughts
Number of subjects: 62
Study 16952896 — intervention group
Group type: EXPERIMENTAL
Intervention: Diagnosis-related automatic thoughts (panic and social phobia)
Number of subjects: 62
Study 12622347 — intervention group
Group type: EXPERIMENTAL
Intervention: d-amphetamine (10 mg)
Number of subjects: 109
Study 12622347 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 109
Study 14971587 — intervention group
Group type: EXPERIMENTAL
Intervention: Levodopa (2 mg/kg body weight)
Number of subjects: 15
Study 14971587 — intervention group
Group type: COMPARATOR
Intervention: Control (normal subjects)
Number of subjects: 15
Study 14971587 — intervention group
Group type: COMPARATOR
Intervention: Baseline comparison
Number of subjects: 15
Study 9588605 — intervention group
Group type: EXPERIMENTAL
Intervention: Functional knee brace (FKB) during aLT tests
Number of subjects: 13
Study 9588605 — intervention group
Group type: COMPARATOR
Intervention: No brace during aLT tests
Number of subjects: 13
Study 9588605 — intervention group
Group type: EXPERIMENTAL
Intervention: Functional knee brace (FKB) during bLT tests
Number of subjects: 13
Study 9588605 — intervention group
Group type: COMPARATOR
Intervention: No brace during bLT tests
Number of subjects: 13
Study 8751022 — intervention group
Group type: EXPERIMENTAL
Intervention: 4% erythromycin plus 1.2% zinc (Zineryt lotion)
Number of subjects: 14
Study 8751022 — intervention group
Group type: COMPARATOR
Intervention: 4% erythromycin lotion (control)
Number of subjects: 14
Study 2371595 — intervention group
Group type: EXPERIMENTAL
Intervention: Portable sleep apnea screening device
Number of subjects: 67
Study 2371595 — intervention group
Group type: COMPARATOR
Intervention: Standard polysomnographic techniques
Number of subjects: 67
Study 90768 — intervention group
Group type: EXPERIMENTAL
Intervention: Concurrent induced-abortion/sterilisation group
Number of subjects: 406
Study 90768 — intervention group
Group type: COMPARATOR
Intervention: Interval sterilisation group
Number of subjects: 406
Study 31395505 — intervention group
Group type: EXPERIMENTAL
Intervention: Anti-VEGF treatment
Number of subjects: 986
Study 28620272 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief Intervention (BI)
Number of subjects: 61
Study 28620272 — intervention group
Group type: COMPARATOR
Intervention: Education Comparison (EC)
Number of subjects: 61
Study 26564297 — intervention group
Group type: EXPERIMENTAL
Intervention: Sugammadex (2 mg/kg intravenously)
Number of subjects: 36
Study 26564297 — intervention group
Group type: COMPARATOR
Intervention: Neostigmine/atropine combination (0.05 mg/kg neostigmine and 0.02 mg/kg atropine)
Number of subjects: 36
Study 26564297 — intervention group
Group type: COMPARATOR
Intervention: Comparison of heart rate and mean arterial pressure
Number of subjects: 36
Study 24277116 — intervention group
Group type: EXPERIMENTAL
Intervention: pemetrexed + carboplatin
Number of subjects: 105
Study 24277116 — intervention group
Group type: COMPARATOR
Intervention: docetaxel + carboplatin
Number of subjects: 105
Study 22319751 — intervention group
Group type: EXPERIMENTAL
Intervention: Ethanol‐wet bonding with experimental hydrophobic adhesive (UT group)
Number of subjects: 66
Study 22319751 — intervention group
Group type: COMPARATOR
Intervention: Water‐wet bonding
Number of subjects: 66
Study 22319751 — intervention group
Group type: EXPERIMENTAL
Intervention: Ethanol‐wet bonding with commercial hydrophilic adhesive (SB)
Number of subjects: 66
Study 19537837 — intervention group
Group type: EXPERIMENTAL
Intervention: Formoterol plus tiotropium
Number of subjects: 155
Study 19537837 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus tiotropium
Number of subjects: 155
Study 16600415 — intervention group
Group type: EXPERIMENTAL
Intervention: Sequential changes in fasting plasma glucose (FPG) levels within the normoglycemic range (FPG<100 mg/dl)
Number of subjects: 5296
Study 16600415 — intervention group
Group type: COMPARATOR
Intervention: Normoglycemic subjects
Number of subjects: 5296
Study 16600415 — intervention group
Group type: COMPARATOR
Intervention: Subjects with impaired fasting glucose
Number of subjects: 5296
Study 15175438 — intervention group
Group type: EXPERIMENTAL
Intervention: Obese children and adolescents
Number of subjects: 490
Study 15175438 — intervention group
Group type: EXPERIMENTAL
Intervention: Overweight and obese subjects
Number of subjects: 490
Study 15175438 — intervention group
Group type: EXPERIMENTAL
Intervention: Increasing obesity
Number of subjects: 490
Study 11342912 — intervention group
Group type: EXPERIMENTAL
Intervention: Transurethral microwave thermotherapy (Prostatron)
Number of subjects: 155
Study 11342912 — intervention group
Group type: COMPARATOR
Intervention: Transurethral prostatic resection
Number of subjects: 155
Study 11342912 — intervention group
Group type: EXPERIMENTAL
Intervention: Transurethral microwave thermotherapy
Number of subjects: 155
Study 9212146 — intervention group
Group type: EXPERIMENTAL
Intervention: I.V. clonidine (3 microg/kg)
Number of subjects: 39
Study 9212146 — intervention group
Group type: COMPARATOR
Intervention: I.V. saline
Number of subjects: 39
Study 8132365 — intervention group
Group type: EXPERIMENTAL
Intervention: Azithromycin 500 mg once daily for 10 days
Number of subjects: 32
Study 8132365 — intervention group
Group type: COMPARATOR
Intervention: Penicillin V 1 million U three times daily for 10 days
Number of subjects: 32
Study 29795028 — intervention group
Group type: EXPERIMENTAL
Intervention: Vocational school students
Number of subjects: 140
Study 29795028 — intervention group
Group type: COMPARATOR
Intervention: High school students
Number of subjects: 140
Study 27596801 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic group (n=10) received Lactobacillus rhamnosus SP1 at a dose of 3×10^9 cfu/day (75 mg/day)
Number of subjects: 20
Study 27596801 — intervention group
Group type: COMPARATOR
Intervention: Placebo group (n=10) received a liquid lacking probiotics
Number of subjects: 20
Study 24145847 — intervention group
Group type: EXPERIMENTAL
Intervention: Noninvasive mechanical ventilation (NIV)
Number of subjects: 15
Study 24145847 — intervention group
Group type: EXPERIMENTAL
Intervention: Marketed device with an off‐switch for use during swallowing
Number of subjects: 15
Study 24145847 — intervention group
Group type: COMPARATOR
Intervention: Standard mechanical ventilator capable of delivering NIV
Number of subjects: 15
Study 22385118 — intervention group
Group type: EXPERIMENTAL
Intervention: Gonadotropin treatment (GnTh) using β Human Chorionic Gonadotropin (β HCG) and Follicle Stimulating Hormone (FSH) for up to 30 months.
Number of subjects: 23
Study 22385118 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG) of 35 healthy and fertile men.
Number of subjects: 23
Study 20299823 — intervention group
Group type: EXPERIMENTAL
Intervention: Urinary cotinine (UC)
Number of subjects: 164
Study 20299823 — intervention group
Group type: COMPARATOR
Intervention: Breath carbon monoxide (CO)
Number of subjects: 164
Study 18211450 — intervention group
Group type: EXPERIMENTAL
Intervention: Airtraq laryngoscope
Number of subjects: 40
Study 18211450 — intervention group
Group type: COMPARATOR
Intervention: Macintosh laryngoscope
Number of subjects: 40
Study 16148244 — intervention group
Group type: EXPERIMENTAL
Intervention: Accompanied visits
Number of subjects: 30
Study 16148244 — intervention group
Group type: COMPARATOR
Intervention: Unaccompanied visits
Number of subjects: 30
Study 12475576 — intervention group
Group type: EXPERIMENTAL
Intervention: Misoprostol 50 microg per vagina every 4 h as needed
Number of subjects: 84
Study 12475576 — intervention group
Group type: EXPERIMENTAL
Intervention: Dinoprostone 0.5 mg doses given intra-cervically every 6 h
Number of subjects: 84
Study 12475576 — intervention group
Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 84
Study 10391423 — intervention group
Group type: EXPERIMENTAL
Intervention: Monitoring with antifactor Xa heparin activity (HA)
Number of subjects: 268
Study 10391423 — intervention group
Group type: COMPARATOR
Intervention: Monitoring with activated partial thromboplastin time (aPTT)
Number of subjects: 268
Study 8655902 — intervention group
Group type: EXPERIMENTAL
Intervention: Fortified formula (alpha-linolenic acid 1.8 g/day, arginine 7.8 g/day, RNA 0.75 g/day)
Number of subjects: 10
Study 8655902 — intervention group
Group type: COMPARATOR
Intervention: Control formula
Number of subjects: 10
Study 8655902 — intervention group
Group type: EXPERIMENTAL
Intervention: Fortified formula
Number of subjects: 10
Study 1504111 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg yohimbine
Number of subjects: 27
Study 1504111 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27
Study 1504111 — intervention group
Group type: EXPERIMENTAL
Intervention: Alprazolam treatment
Number of subjects: 27
Study 1504111 — intervention group
Group type: EXPERIMENTAL
Intervention: Mental arithmetic task
Number of subjects: 27
Study 1504111 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous performance task
Number of subjects: 27
Study 1504111 — intervention group
Group type: EXPERIMENTAL
Intervention: Yohimbine
Number of subjects: 27
Study 6746158 — intervention group
Group type: EXPERIMENTAL
Intervention: Viewing alcohol-related slides
Number of subjects: 16
Study 6746158 — intervention group
Group type: COMPARATOR
Intervention: Viewing non-alcohol-related slides
Number of subjects: 16
Study 29404890 — intervention group
Group type: EXPERIMENTAL
Intervention: Supreme™ LMA (SLMA)
Number of subjects: 60
Study 29404890 — intervention group
Group type: COMPARATOR
Intervention: Proseal™ LMA (PLMA)
Number of subjects: 60
Study 26726986 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical nerve stimulation device
Number of subjects: 0
Study 26726986 — intervention group
Group type: COMPARATOR
Intervention: Standard nonoperative modalities
Number of subjects: 0
Study 18252029 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam and Ketamine
Number of subjects: 114
Study 18252029 — intervention group
Group type: COMPARATOR
Intervention: Propofol
Number of subjects: 114
Study 18252029 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam and Ketamine (Cyanotic subgroup)
Number of subjects: 114
Study 18252029 — intervention group
Group type: COMPARATOR
Intervention: Propofol (Cyanotic subgroup)
Number of subjects: 114
Study 21931958 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness training (8-week course)
Number of subjects: 0
Study 21931958 — intervention group
Group type: COMPARATOR
Intervention: Waiting list control group
Number of subjects: 0
Study 18696227 — intervention group
Group type: EXPERIMENTAL
Intervention: Fear elicitation task (N = 33)
Number of subjects: 73
Study 18696227 — intervention group
Group type: EXPERIMENTAL
Intervention: Frustration elicitation task (N = 32)
Number of subjects: 73
Study 18696227 — intervention group
Group type: COMPARATOR
Intervention: Validity check condition (N = 8)
Number of subjects: 73
Study 17935933 — intervention group
Group type: EXPERIMENTAL
Intervention: Sufentanil 5 microg and Clonidine 30 microg (C30)
Number of subjects: 105
Study 17935933 — intervention group
Group type: EXPERIMENTAL
Intervention: Sufentanil 10 microg (S10)
Number of subjects: 105
Study 17935933 — intervention group
Group type: COMPARATOR
Intervention: Sufentanil 5 microg (S5)
Number of subjects: 105
Study 15864406 — intervention group
Group type: EXPERIMENTAL
Intervention: Feature fusion mechanism in schizophrenia
Number of subjects: 0
Study 12462952 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary supplement 'ExPress'
Number of subjects: 24
Study 9833720 — intervention group
Group type: EXPERIMENTAL
Intervention: Autologous cryoprecipitate
Number of subjects: 32
Study 9833720 — intervention group
Group type: COMPARATOR
Intervention: Conventional fibrin glue
Number of subjects: 32
Study 8209990 — intervention group
Group type: EXPERIMENTAL
Intervention: Stifneck cervical collar
Number of subjects: 9
Study 8209990 — intervention group
Group type: COMPARATOR
Intervention: No cervical collar
Number of subjects: 9
Study 2684078 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral ciprofloxacin (750 mg every 12 hours)
Number of subjects: 570
Study 2684078 — intervention group
Group type: COMPARATOR
Intervention: Intravenous cefotaxime (2.0 g every 8 hours)
Number of subjects: 570
Study 2684078 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral ciprofloxacin
Number of subjects: 570
Study 240378 — intervention group
Group type: EXPERIMENTAL
Intervention: Atenolol (50 mg oral dose)
Number of subjects: 5
Study 240378 — intervention group
Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 5
Study 31581926 — intervention group
Group type: EXPERIMENTAL
Intervention: Sacubitril/valsartan initiation
Number of subjects: 143
Study 30707238 — intervention group
Group type: EXPERIMENTAL
Intervention: Curved suture anchor insertion technique
Number of subjects: 20